Trial intelligence / Profile preview

Perioperative dexmedetomidine infusion in pre-eclamptic women undergoing elective cesarean section under general anesthesia

PACTR202412834702557Phase 4Completed

Sponsor
Al-Azhar University Hospitals
Start
Nov 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of dexmedetomidine in preeclampsia, sponsored by Al-Azhar University Hospitals. Primary endpoints: Intraoperative heart rate, Intraoperative systolic blood pressure and 1 more. Started Nov 2021; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

preeclampsia

Beyond the preview

Go deeper on PACTR202412834702557.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202412834702557.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call